AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 29.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,452,000 | -14.1% | 2,325,107 | +16.2% | 0.00% | – |
| Q3 2019 | $1,690,000 | +25.7% | 2,000,148 | +0.1% | 0.00% | – |
| Q2 2019 | $1,345,000 | -77.2% | 1,997,793 | -72.2% | 0.00% | – |
| Q1 2019 | $5,904,000 | -49.9% | 7,198,812 | -2.2% | 0.00% | -100.0% |
| Q4 2018 | $11,773,000 | -50.1% | 7,357,716 | +3.3% | 0.00% | 0.0% |
| Q3 2018 | $23,570,000 | +49.5% | 7,120,894 | +2.1% | 0.00% | 0.0% |
| Q2 2018 | $15,770,000 | +189.8% | 6,977,746 | +271.9% | 0.00% | – |
| Q1 2018 | $5,442,000 | +3.7% | 1,876,465 | -0.3% | 0.00% | – |
| Q4 2017 | $5,250,000 | -23.5% | 1,881,759 | +0.1% | 0.00% | – |
| Q3 2017 | $6,862,000 | +65.5% | 1,880,107 | +0.6% | 0.00% | – |
| Q2 2017 | $4,147,000 | +255.1% | 1,868,220 | -5.6% | 0.00% | – |
| Q1 2017 | $1,168,000 | – | 1,979,889 | +295847.5% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 669 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 669 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 669 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 669 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 669 | +234.5% | 0.00% | – |
| Q3 2013 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |